ImmunityBio shows strong commercial momentum with ANKTIVA, reporting significant revenue growth and improved net loss in Q3.
There’s an effort underway to rally federal lawmakers representing Minnesota to push the Trump administration to scale back a recently enacted ban on hemp-derived THC by providing a carve-out for ...
The community-based pharmacy concept remains a dream rather than a reality, and it might be time to consider a move back to ...
Nigerians view Trump’s threats as a classic form of imperialist intervention under the guise of “protecting Christians from ...
Amgen (NASDAQ: AMGN) announced today that the U.S. Food and Drug Administration (FDA) has granted full approval to IMDELLTRA® (tarlatamab-dlle) for the treatment of adult patients with extensive stage ...
The U.S. war on drugs has always entailed a degree of pressure. The Trump administration's strikes on suspected ...
The 74 on MSN
Vaping Is ‘Everywhere Now’ in Schools. Can Bathroom Surveillance Tech Solve the Problem or Just Escalate Suspensions?
Vape detector logs reveal an avalanche of alerts, suspensions dwarfing treatment services and younger kids being punished ...
Baxter International Inc. (NYSE:BAX) ("Baxter" or the "Company") today announced that it has increased the maximum purchase price for its $1.45 billion aggregate principal amount outstanding of 1.915% ...
AlphaTON Capital Corp. (Nasdaq: ATON) ("AlphaTON" or the "Company"), a specialized digital asset technology company focused on the Telegram ecosystem, ...
PharmaTEC Pharmaceutical Engineering International Forum, this meeting brought together over 30 experts, scholars, and ...
A significant development emerged on November 13 when Pfizer announced it had sold 54.7% of its stake in BioNTech, retaining only $163.5 million worth of shares. This move marks a substantial shift in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback